Stacy A Rudnicki

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Amyotrophic Lateral Sclerosis

Placebo Controlled

Top Venues

Amyotrophic lateral sclerosis & frontotemporal degeneration

This page only lists publications with an associated author ORCID identifier.

Publications

Jeremy M Shefner, Bill Jacobsen, Stuart Kupfer, Fady I Malik, Lisa Meng, Jenny Wei, Andrew A Wolff, Stacy A Rudnicki
Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Jeremy M Shefner, Ammar Al Chalabi, Jinsy A Andrews, Adriano Chio, Mamede de Carvalho, Bettina M Cockroft, Philippe Corcia, Philippe Couratier, Merit E Cudkowicz, Angela Genge, Orla Hardiman, Terry D Heiman-Patterson, Robert David Henderson, Caroline Ingre, Carlayne E Jackson, Wendy Johnston, Noah Lechtzin, Albert C Ludolph, Nicholas J Maragakis, Timothy M Miller, Jesus S Mora, Susanne Petri, Zachary Simmons, Leonard H Van Den Berg, Lorne Zinman, Stuart Kupfer, Fady I Malik, Lisa Meng, Tyrell J Simkins, Jenny Wei, Andrew A Wolff, Stacy A Rudnicki
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success. Amyotrophic lateral sclerosis & frontotemporal degeneration (2023)
Paulos Gebrehiwet, Lisa Meng, Stacy A Rudnicki, Phil Sarocco, Jenny Wei, Andrew A Wolff, Adriano Chio, Jinsy A Andrews, Angela Genge, Carlayne E Jackson, Noah Lechtzin, Timothy M Miller, Jeremy M Shefner
MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial. Amyotrophic lateral sclerosis & frontotemporal degeneration (2022)